Xiaoyan Lin

机构：Fujian Medical University, Yantaishan Hospital, Union Hospital · ORCID：0009-0007-1523-4538

发表论文 80 篇 · 总被引 997 次 · h-index 18

代表论文

• Cadonilimab with chemotherapy in HER2-negative gastric or gastroesophageal junction adenocarcinoma: the phase 1b/2 COMPASSION-04 trial (2024 · Nature Medicine · 被引 49)
• Senaparib as first-line maintenance therapy in advanced ovarian cancer: a randomized phase 3 trial (2024 · Nature Medicine · 被引 45)
• Targeting cTRIP12 counteracts ferroptosis resistance and augments sensitivity to immunotherapy in pancreatic cancer (2025 · Drug Resistance Updates · 被引 39)
• Research progress on the preparation, performance, mechanisms, and applications of carbon nanomaterials against Gram-negative bacteria (2025 · RSC Advances · 被引 18)
• Dextran guanidinylated carbon dots with antibacterial and immunomodulatory activities as eye drops for the topical treatment of MRSA-induced infectious keratitis (2025 · Acta Biomaterialia · 被引 17)
• TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis (2025 · Cancer Research · 被引 8)